Unlocking Bio/Pharma Potential: The Strategic Advantages of Outsourcing to CMOs and CDMO

Contract organisations, notably Contract Manufacturing Organisations (CMOs) and Contract Development and Manufacturing Organisations (CDMOs), have become integral to the pharmaceutical and biotech sectors. They offer sponsor companies flexibility by providing additional capacity, specialised expertise, and potential cost savings. This is particularly beneficial for smaller bio/pharma companies that may lack extensive in-house resources.

As featured in European Pharmaceutical Manufacturer magazine, this article offers an insight into how contract organisations provide flexibility, expertise, and cost savings, and what sponsor companies need to consider for successful partnerships.